Cancer and heart disease, two leading causes of death worldwide, may be more connected than we previously thought, according ...

Cancer and heart disease, two leading causes of death worldwide, may be more connected than we previously thought, according ...

The findings provide insight into which patients may have favorable or inferior responses to immunotherapy for small cell ...

According to a recent study published in JACC: Advances, researchers have discovered that certain blood markers typically ...

Biomarker-targeted adjuvant therapy improved survival in early-stage NSCLC, highlighting the importance of testing and ...

As immunotherapy becomes a cornerstone of cancer treatment, some of the top U.S. cancer centers and health systems are accelerating research efforts to identify the biological mechanisms behind ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, and Noetik, a leader in AI-driven spatial and multimodal biology, today announced a research collaboration to develop predictive ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Suresh S. Ramalingam, MD, FACP, FASCO, emphasizes the role of community oncologists in translating new advancements in lung cancer research into widespread patient benefit.